Final overall survival and long-term safety in the ENGOT-OV16/NOVA phase III trial of niraparib in patients with recurrent ovarian cancer (LBA 6)

Ursula A. Matulonis, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Dominique Berton-Rigaud, Jonathan S. Berek, Charlotte Aaquist Haslund, Frederik Marmé, Antonio González-Martı́n, Stéphanie Bécourt, Anna V. Tinker, Jonathan A. Ledermann, Benedict B. Benigno, Gabriel Lindahl, Nicoletta Colombo, Izabela Malinowska, Wenlei Liu, Michael Schmitz, Bradley J. Monk, Mansoor Raza Mirza